Primary and metastatic tumors exhibit a high concordance of genomic alterations, including oncogenic mutations of KRAS and TP53. Two studies of various primary tumors show that matched metastatic regions exhibit a high degree of similarity with respect to genomic alterations33,34. This evidence concerns the gene TP53 and metastatic neoplasm.